We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $83.9 · 10 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
HALO Stock Chart | HALOZYME THERAPEUTICS INC (NASDAQ:HALO) - ChartMill
HALO Stock Chart | HALOZYME THERAPEUTICS INC (NASDAQ:HALO) ChartMill
HALO Stock Price, Quote & Chart | HALOZYME THERAPEUTICS INC (NASDAQ:HALO) - ChartMill
HALO Stock Price, Quote & Chart | HALOZYME THERAPEUTICS INC (NASDAQ:HALO) ChartMill
Halozyme Therapeutics Inc at Leerink Global Healthcare Conference Transcript - GuruFocus
Halozyme Therapeutics Inc at Leerink Global Healthcare Conference Transcript GuruFocus
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 04. | After market close (AMC) | $1.82 | — | — | $403.98M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.93 | — | — | $264.86M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $2.37 | — | — | $717.32M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $1.32 | — | — | $427.23M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 13. | Morgan Stanley | — | Maintain | Overweight → Overweight | — | Morgan Stanley: Overweight |
| 2026. 04. 29. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 02. 20. | Benchmark | — | Maintain | Buy → Buy | — | Benchmark: Buy |
| 2026. 02. 19. | Wells Fargo | — | Maintain | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
| 2026. 01. 09. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2025. 12. 19. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 1,584,961 | $102.44B | 0.09% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 717,369 | $48.28B | 0.08% | — | New position |